AML Insights – June Update: What’s New in the Field
Discover the key developments in the treatment of acute myeloid leukemia, including advances in CAR-T cell and NK cell therapies, new combination regimens such as venetoclax with hypomethylating agents, and targeted chemotherapy using anti-CD33 antibodies.
Don’t miss these exciting developments!
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
